Zelluna, a pioneer in TCR-NK cell therapy for cancer, will host an Investor Science and Strategy Forum in Oslo on 17 September 2025. The panel includes Dr. Namir Hassan, Prof. Bent Jakobsen, and Prof. Fiona Thistlethwaite. The event will feature a panel discussion and open Q&A session. Attendance is by registration only, with limited spaces available. The forum aims to discuss the company’s mission to deliver transformative cancer treatments using TCR-NK cell therapies. For more information and registration details, visit Zelluna’s website.

Read more at GlobeNewswire: Zelluna Announces Investor Forum on Science & Strategy to